84
Views
21
CrossRef citations to date
0
Altmetric
Review

Antiplatelet drugs in cardiological practice: Established strategies and new developments

, &
Pages 637-645 | Published online: 06 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

J Lasierra-Cirujeda, P Coronel, MJ Aza & M Gimeno. (2010) Use of sulodexide in patients with peripheral vascular disease. Journal of Blood Medicine 1, pages 105-114.
Read now

Articles from other publishers (20)

Ayesha Ramzan, Areesha Nazeer, Ahmad Irfan, Abdullah G. Al-Sehemi, Francis Verpoort, Zafar A. Khatak, Aftab Ahmad, Munawar A. Munawar, Misbahul A. Khan & Muhammad Asim Raza Basra. (2019) Synthesis and Antiplatelet Potential Evaluation of 1,3,4-Oxadiazoles Derivatives. Zeitschrift für Physikalische Chemie 233:12, pages 1741-1759.
Crossref
Chih-Hao Yang, Chih-Wei Hsia, Thanasekaran Jayakumar, Joen-Rong Sheu, Chih-Hsuan Hsia, Themmila Khamrang, Yen-Jen Chen, Manjunath Manubolu & Yi Chang. (2018) Structure–Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases. International Journal of Molecular Sciences 19:11, pages 3641.
Crossref
Flavio Dormont, Mariana Varna & Patrick Couvreur. (2018) Nanoplumbers: biomaterials to fight cardiovascular diseases. Materials Today 21:2, pages 122-143.
Crossref
R. Kini & Cho Koh. (2016) Metalloproteases Affecting Blood Coagulation, Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites. Toxins 8:10, pages 284.
Crossref
Moiz I. Manaqibwala, Katherine A. Butler & Carlos A. Sagebien. (2014) Complications of hip fracture surgery on patients receiving clopidogrel therapy. Archives of Orthopaedic and Trauma Surgery 134:6, pages 747-753.
Crossref
Charles V. PollackJr.Jr., Alpesh Amin, Tomas Villanueva, Frank Peacock, Richard Summers, George Davatelis & Scott Kaatz. (2014) Rationale for Upstream Dual Antiplatelet Therapy in Non-ST-Segment Elevation Myocardial Infarction. Current Emergency and Hospital Medicine Reports 2:1, pages 76-89.
Crossref
Narenda Kumar & Rajiv Kumar. 2014. Nanotechnology and Nanomaterials in the Treatment of Life-threatening Diseases. Nanotechnology and Nanomaterials in the Treatment of Life-threatening Diseases 247 298 .
Wissam Abouzgheib, Nikhil Meena, Prashant Jagtap, Christa Schorr, Ziad Boujaoude & Thaddeus Bartter. (2013) Percutaneous Dilational Tracheostomy in Patients Receiving Antiplatelet Therapy. Journal of Bronchology & Interventional Pulmonology 20:4, pages 322-325.
Crossref
WISSAM ABOUZGHEIB, YOUSEF R. SHWEIHAT, NIKHIL MEENA & THADDEUS BARTTER. (2012) Is chest tube insertion with ultrasound guidance safe in patients using clopidogrel?. Respirology 17:8, pages 1222-1224.
Crossref
C. LI, J. HIRSH, C. XIE, M.A. JOHNSTON & J.W. EIKELBOOM. (2012) Reversal of the anti‐platelet effects of aspirin and clopidogrel. Journal of Thrombosis and Haemostasis 10:4, pages 521-528.
Crossref
Erin M. Walsh & Cezary Marcinkiewicz. (2011) Non-RGD-containing snake venom disintegrins, functional and structural relations. Toxicon 58:4, pages 355-362.
Crossref
Hillary A. Johnston-Cox & Katya Ravid. (2011) Adenosine and blood platelets. Purinergic Signalling 7:3, pages 357-365.
Crossref
Bijo K. John, Sushma Arramraju, Albert Shalomov, Cristina Sison & Moshe Rubin. (2011) Antiplatelet Agents Do Not Impact the Hospital Course in Patients With Gastrointestinal Bleeding. Journal of Clinical Gastroenterology 45:7, pages 583-589.
Crossref
Daniel R. Lewis, Kubra Kamisoglu, Adam W. York & Prabhas V. Moghe. (2011) Polymer‐based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 3:4, pages 400-420.
Crossref
Hillary A. Johnston-Cox, Dan Yang & Katya Ravid. (2011) Physiological implications of adenosine receptor-mediated platelet aggregation. Journal of Cellular Physiology 226:1, pages 46-51.
Crossref
Graeme J Hankey & John W Eikelboom. (2010) Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. The Lancet Neurology 9:3, pages 273-284.
Crossref
RB Geraldo, ML Bello, LRS Dias, MAF Vera, T Nagashima, PA Abreu, MB Santos, MG Albuquerque, LM Cabral, ACC Freitas, MV Kalil, CR Rodrigues & HC Castro. (2010) Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases. Journal of Atherosclerosis and Thrombosis 17:7, pages 730-739.
Crossref
Rafael García-Hernández, María Vidal, Carmen Sebastianes & Luis M. Torres. 2010. Tratado de Medicina Transfusional Perioperatoria. Tratado de Medicina Transfusional Perioperatoria 371 381 .
Connye N. Kuratko, James P. Hoffman, Mary E. Van Elswyk & Norman SalemJrJr. 2010. Single Cell Oils. Single Cell Oils 369 387 .
V. Hombach. (2009) Neuentwicklungen in der Thrombozytenaggregationshemmung – sinnvolle Alternativen für ASS/Clopidogrel-Non-Responder?Recent developments in platelet aggregation inhibitors – useful alternatives for the ASS/clopidogrel nonresponder?. Clinical Research in Cardiology Supplements 4:S2, pages 184-191.
Crossref